Not applicableWithdrawnNCT03625336What this trial is testingMR Imaging of Prostatic CalcificationsWho this might be right forProstate Calcification Vanderbilt University Medical Center
Large-scale testing (Phase 3)Study completedNCT00048841What this trial is testingPrevention of Osteoporosis in Men With Prostate CancerWho this might be right forProstate CancerOsteoporosisHypogonadism National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 112
Large-scale testing (Phase 3)Study completedNCT00925600What this trial is testingEvaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone LossWho this might be right forCancerCataractLow Bone Mineral Density+3 more Amgen 769
Post-approval studies (Phase 4)Study completedNCT00063609What this trial is testingThe Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation TherapyWho this might be right forProstate Cancer Novartis Pharmaceuticals 200
Not applicableStudy completedNCT02043236What this trial is testingStrategies to Improve Bone Health in Men on ADTWho this might be right forProstate Cancer University Health Network, Toronto 159
Not applicableStudy completedNCT00176579What this trial is testingBone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate CancerWho this might be right forOsteoporosisProstate Cancer University of Medicine and Dentistry of New Jersey 27
Not applicableStudy completedNCT00536653What this trial is testingChanges in Bone Mineral Density and Fracture Risk in Patients Receiving Androgen Deprivation Therapy for Prostate CancerWho this might be right forOsteoporosis Wirral University Teaching Hospital NHS Trust 618
Large-scale testing (Phase 3)Study completedNCT00426777What this trial is testingEfficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate CancerWho this might be right forProstate Cancer CMX Research 160
Not applicableEnded earlyNCT02177526What this trial is testingImaging of High Grade Prostate CancerWho this might be right forProstatic Carcinoma Ottawa Hospital Research Institute 30
Large-scale testing (Phase 3)Ended earlyNCT00391950What this trial is testingMaintaining Bone Strength in Men With Prostate CancerWho this might be right forProstate Cancer Novartis 300
Not applicableStudy completedNCT00489905What this trial is testingStudy on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate CancerWho this might be right forProstatic NeoplasmsBone Density Hospital Authority, Hong Kong 24
Post-approval studies (Phase 4)UnknownNCT03202381What this trial is testingPhase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With DegarelixWho this might be right forProstate Cancer Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 35
Post-approval studies (Phase 4)UnknownNCT04248621What this trial is testingAndrogen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer PatientsWho this might be right forProstatic Neoplasms Wonju Severance Christian Hospital 164
Not applicableStudy completedNCT00551044What this trial is testingBicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate CancerWho this might be right forProstatic Neoplasms Wirral University Teaching Hospital NHS Trust 42
Not applicableLooking for participantsNCT06259279What this trial is testingHigh Impact Training to Patients with Prostate Cancer and Bone MetastasesWho this might be right forProstate Cancer Copenhagen University Hospital at Herlev 102
Not applicableStudy completedNCT02064946What this trial is testingHigh-dose Vitamin D Supplementation for ADT-induced Side EffectsWho this might be right forProstatic NeoplasmsBone Mineral Density Quantitative Trait Locus 3 University of Rochester 108
Testing effectiveness (Phase 2)Study completedNCT00582556What this trial is testingZometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation TherapyWho this might be right forProstate Cancer University of Wisconsin, Madison 44
Not applicableStudy completedNCT01303692What this trial is testingComparison of Bone Mineral Loss in Prostate Cancer Patients Who is Receiving GnRH Agonist and -Plus Anti-androgen AgentWho this might be right forGnRH Agonist Alone vs. GnRH Agonist Plus Anti-androgen Combination Treated Prostate Cancer Patients AstraZeneca 312
Post-approval studies (Phase 4)Study completedNCT00035997What this trial is testingOpen-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone MetastasisWho this might be right forProstate Cancer Novartis Pharmaceuticals 261